ESR1 and breast cancer: Overexpression of ERα is thought to be an initial event in the development of ER positive breast cancer and in utero exposure to endocrine disrupting chemicals has been shown to alter expression of ERα in the mammary glands of exposed offspring [67,68,69,70].